Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Doxazosin 4 MG Oral Tablet

Known as: DOXAZOSIN MESYLATE 4 mg ORAL TABLET [Doxazosin], DOXAZOSIN MESYLATE 4 mg ORAL TABLET [Doxazosin mesylate], DOXAZOSIN MESYLATE 4MG TAB 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
This study sought to investigate the clinical efficacy and safety of combined oral therapy with sildenafil and doxazosin GITS… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Highly Cited
2004
Highly Cited
2004
Previous studies have shown that a single nighttime dose of standard doxazosin, an α-adrenergic antagonist, reduces blood… Expand
2004
2004
An analysis is presented to compare the efficacies of the doxazosin gastrointestinal therapeutic system (doxazosin‐GITS) and… Expand
Highly Cited
2003
Highly Cited
2003
  • R. Kirby
  • BJU international
  • 2003
  • Corpus ID: 32898493
To compare the effects of the doxazosin gastrointestinal therapeutic system, extended‐release (doxazosin‐GITS) formulation, and… Expand
2003
2003
The objective of this prospective, randomized, open‐label, parallel‐arm comparative study, with a 4‐month follow‐up, was to… Expand
Highly Cited
2001
Highly Cited
2001
Objective To report an integrated analysis of two previous studies fully characterizing the clinical utility of the controlled… Expand
Highly Cited
2000
Highly Cited
2000
Background: The α1–blocker doxazosin mesylate is an established efficacious and welltolerated treatment for benign prostatic… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
2000
2000
BACKGROUND AND METHOD This randomized, doubleblind, multicenter, parallel-group, placebo-baseline study compared the effects of… Expand
1999
1999
The alpha 1-blocker doxazosin is a well-established therapy for hypertension and benign prostatic hyperplasia; however, in its… Expand
1999
1999
Doxazosin, an effective treatment for mild-to-moderate hypertension and benign prostatic hyperplasia, in its standard formulation… Expand